Microbot Medical, the developer of the LIBERTY Endovascular Robotic System, has announced a Phase 2 collaboration agreement with Corewell Health, a Michigan-based healthcare system.
This agreement follows the completion of Phase 1, which evaluated the viability of LIBERTY as a remote telesurgery platform. The new phase will focus on developing and demonstrating advanced telesurgery capabilities by conducting simulated interventional procedures across two Corewell Health facilities located in West Michigan.
In this second phase, Microbot Medical and Corewell Health will work together to enhance the LIBERTY system’s ability to perform remote cardiovascular interventional procedures. The collaboration aims to refine the technology and showcase its effectiveness in real-world scenarios.
Ryan Madder, section chief of interventional cardiology and director of the cardiac cath lab at Corewell Health in West Michigan, will lead the project.
Microbot Medical CEO, president, and chairman Harel Gadot said: “Incorporating telesurgery capabilities is an important part of our long-term strategy for LIBERTY.
“We believe that physicians in the U.S. and around the globe want to increase access to care for patients in remote locations, and we are excited to continue our collaboration with Corewell Health and Dr. Madder on this next phase of development.”
Microbot Medical, listed on NASDAQ, is a clinical-stage medical device company specialising in transformational micro-robotic technologies. The company aims to improve clinical outcomes and enhance accessibility through natural and artificial lumens within the human body.
The LIBERTY Endovascular Robotic Surgical System seeks to improve the application of surgical robotics in endovascular procedures by eliminating the need for large, cumbersome, and costly equipment. It also aims to reduce radiation exposure and decrease physician strain.
Microbot Medical believes that the LIBERTY System’s remote operation has the potential to democratise endovascular interventional procedures.
Recently, the company partnered with US-based Emory University to explore future autonomous capabilities of the LIBERTY System. Project Trita will see Emory University leading an evaluation to integrate LIBERTY with an imaging system.
This collaboration aims to develop an autonomous robotic system for endovascular procedures, with a focus on integrating procedure planning and navigation into a single autonomous system.
